enGene (NasdaqCM:ENGN) 2026 Conference Transcript

enGene (NasdaqCM:ENGN) 2026 Conference February 11, 2026 02:30 PM ET Company ParticipantsRon Cooper - CEOConference Call ParticipantsMichael Schmidt - Senior Biotech AnalystMichael SchmidtWelcome to this next Fireside Chat. My name is Michael Schmidt, Senior Biotech Analyst with Guggenheim, and with us today we have Ron Cooper, CEO of enGene Therapeutics. Ron, welcome. Thanks for joining us.Ron CooperWell, thanks for the invitation. Great to be here.Michael SchmidtSo Ron, you're in the non-muscle invasive b ...